Martin Shkreli

UBS Financial Services' asset allocations are based on a proprietary methodology. In developing those allocations, the firm considers asset class risk and return results that are based on estimated forward-looking return and risk assumptions, as measured by standard deviation, which are based on UBS proprietary research. The development process includes a review of a variety of factors, including the return, risk, correlations and historical performance of various asset classes, inflation and risk premium.

Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases

Intrepid Capital is focused on pursuing superior risk-adjusted returns over full market cycles. The firm’s disciplined research process, conservative valuation methodology, and contrarian mindset are the cornerstone of their investment philosophy. Their research is done internally following a bottom-up, value-based strategy.

Operates as a capital pool company

Functions as a College/University

Elea Capital Management invests in the healthcare sector

Provides investment advice

Provides biotechnology services

Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases